Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: Lazarus who wrote (166977)	1/12/2021 4:10:32 AM
From: TobagoJack	1 Recommendation Recommended By marcher Respond to of 218724

Team HK seems unwilling to be bum-rushed where perhaps no bums ought to rush The Team ordered 22M doses ~evenly divided amongst Sinovac, BioNTech-Fosun (China JV), and AstraZeneca-Oxford. BioNTech for world ex-China is partnered w/ Pfizer HK shall see what happens elsewhere before heading anywhere w/ our 8M souls. admedilink.hk bloomberg.com No Rush to Roll Out Covid-19 Vaccines in Hong Kong, Advisers Say Iain Marlow Hong Kong is in no hurry to roll out Covid-19 vaccinations, according to government advisers, preferring instead to see what happens in other, harder-hit places. “We have the luxury of a bit of time to observe how the program is being rolled out elsewhere, especially on the safety side,” Lam Ching-choi, a medical doctor and member of the Chief Executive’s advisory Executive Council, said in an interview on Monday. “Our experts are not in a hurry to be the first to be doing a vaccination program. We’re finding a balance between not having the vaccine late, and having adequate supplies, and we have the luxury to know that the vaccine we’ve purchased is safe.” Unlike the U.S., the U.K. and China, which have administered millions of vaccinations since December, Hong Kong has yet to authorize a vaccine and doesn’t plan to begin inoculations until February. Officials already declined to receive a January shipment of Sinovac vaccines because regulatory approval was pending, according to Lam. The city has purchased enough doses -- a mix of the Pfizer Inc.- BioNTech SE, Sinovac Biotech Ltd. and AstraZeneca Plc vaccines -- to cover its 7.5 million residents, and plans to offer people a choice of which vaccine they’ll take. Hong Kong has reported just 9,283 coronavirus cases since the pandemic began, making it one of the most Covid-resilient places in the world. But the city is now struggling to contain a fourth wave that has resurrected tight social distancing requirements and frustrated local businesses -- especially restaurants -- and parents of school-age children. Authorities have reported between 25 and 60 daily cases over the last week. The city has also seen 159 deaths from Covid-19 -- still roughly half of the total death toll inflicted on Hong Kong from severe acute respiratory syndrome, or SARS, which killed nearly 300 people in the early 2000s. The Best and Worst Places to Be in Covid: U.S. Sinks in Ranking In separate comments on Tuesday, Chief Executive Carrie Lam noted that rolling out vaccines wouldn’t bring an immediate end to social distancing. Hong Kong’s government didn’t immediately respond Tuesday to further inquiries about the vaccination program. The cautious approach could result in wider public acceptance of the vaccines once they become available, according to David Hui, a professor of respiratory medicine at the Chinese University of Hong Kong and a member of the government’s Covid-19 advisory panel. “It’s good that we have data from North America and also the U.K. -- which have already commenced the vaccination program -- to show us more information about the unknown side effects, such as severe allergic reaction, so we can have better preparation,” Hui said. Before it's here, it's on the Bloomberg Terminal. LEARN MORE